Sanofi

Information for Connecticut Prescribers of Prescription Drugs Provided Pursuant to Connecticut House Bill 6669

This information is intended for Connecticut Prescribers

HB 6669

 

Diabetes Products

Last Update: January 21, 2026

Form

Vaccines

Last Update: January 21, 2026

Form

ALDURAZYME® (laronidase)

Last Update: January 01, 2026

Form

ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]

Last Update: January 01, 2026

Form

ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]

Last Update: January 01, 2026

Form

CABLIVI® (caplacizumab-yhdp)

Last Update: January 01, 2026

Form

CERDELGA® (eliglustat) capsules, for oral use

Last Update: January 01, 2026

Form

Cerezyme® (imiglucerase) for injection

Last Update: January 01, 2026

Form

DUPIXENT® (dupilumab) Injection

Last Update: January 01, 2026

Form

Elitek® (rasburicase) IV infusion

Last Update: July 01, 2025

Form

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]

Last Update: January 03, 2025

Form

FABRAZYME® (agalsidase beta) for injection, for intravenous use

Last Update: January 01, 2026

Form

Jevtana® (cabazitaxel) injection

Last Update: January 01, 2026

Form

KEVZARA® (sarilumab)

Last Update: January 01, 2026

Form

LEMTRADA® (alemtuzumab)

Last Update: July 01, 2025

Form

LUMIZYME® (alglucosidase alfa)

Last Update: January 01, 2026

Form

MULTAQ® (dronedarone)

Last Update: January 01, 2026

Form

NEXVIAZYME® (avalglucosidase alfa-ngpt) for injection, for intravenous use

Last Update: January 01, 2026

Form

Qfitlia™ (fitusiran) injection

Last Update: January 01, 2026

Form

REZUROCK® (belumosudil) tablets

Last Update: January 01, 2026

Form

SARCLISA® (isatuximab-irfc) injection

Last Update: January 01, 2026

Form

Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]

Last Update: January 01, 2026

Form

THYROGEN® (thyrotropin alfa for injection)

Last Update: January 01, 2026

Form

TZIELD® (teplizumab-mzwv)

Last Update: January 01, 2026

Form

WAYRILZ™ (rilzabrutinib) tablets

Last Update: January 21, 2026

Form

XENPOZYME® (olipudase alfa-rpcp) for injection, for intravenous use

Last Update: January 01, 2026

Form

 

House Bill 6669. Published by the General Assembly of the State of Connecticut    

Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Cerezyme, Elitek, Fabrazyme, Jevtana, Kevzara, Lemtrada, Lumizyme, Multaq, Nexviazyme, Qfitlia, Thymoglobulin , Xenpozyme

 

MAT-US-2308341-v7.0-09/2025